Teva Pharmaceutical Industries Ltd. Web Site www.tevapharm.com Contact: Dan Suesskind Chief Financial Officer Teva Pharmaceu
TEVA REPORTS SECOND QUARTER 2013 RESULTS Net Revenues of $4.9 Billion Non-GAAP Diluted EPS of $1.20, GAAP Diluted EPS Loss of $0
![Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports. Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.](https://data.cbonds.com/organisations_logos/13739/1506089713teva.png)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
1 • Quarterly Net Sales of $2,286 Million, up 74% • Net Income of $606 Million, up 127% • Fully Diluted EPS of $0.74, u
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
Website: www.tevapharm.com FOR IMMEDIATE RELEASE TEVA REPORTS FIRST QUARTER 2006 RESULTS Results include IVAX for the first tim
![Actavis Pharma (A Teva Company) – Walk-In Interviews for Multiple Openings on 30th July' 2022 - Pharmawisdom.co.in Actavis Pharma (A Teva Company) – Walk-In Interviews for Multiple Openings on 30th July' 2022 - Pharmawisdom.co.in](https://i0.wp.com/pharmawisdom.co.in/wp-content/uploads/2022/07/Act.jpg)